Transcend · Navigate.pptx
V0.1
1
1
2
1
3
4
1
5
1
6
1
7
8
9
10
1
11
12
1
13
1
14
1
15
1
Review anomalies:10
This comment is Generated by AI
Audience Restriction / Material Type Mismatch
P1:
The claim is inconsistent with the material type. Please revise accordingly.
Extreme Wording Alert (Superlative)
P2:
Absolute/Superlative language detected. Please remove or rephrase for a more balanced tone.
Competitor Disparagement / Unfair Comparison
P4:
Disparagement of competitors is prohibited under competition regulations. Please revise to ensure a fair and objective comparison
Unsupported Absolute Claim
P5:
This is an absolute claim ('First Approved'). Please provide supporting references or official regulatory documentation to verify this statement.
Typographical Error
P6:
Typos.
Off-label Use Risk
P10:
This is an offlabel study of Drug A, please double check whether to remove or add a disclaimer based on LOC's regulations.
Incorrect Product-related Visual
P12:
Incorrect product icon/visual. Please revise.
National Symbol / Compliance Visual Issue
P13:
Inaccurate national symbols. Please update to the official version.
Extreme Wording Alert (Superlative)
P14:
Absolute/Superlative language detected. Please remove or rephrase for a more balanced tone.
Abbreviated Prescribing Information Reminder
P15:
Abbreviated Prescribing Information (aPI) for Drug A is required.